Table 2

Within-group change in TASQ after TAVR or SAVR

	TAVR			SAVR
	n	Paired difference versus baseline (95% CI)	P value	n	Paired difference versus baseline (95% CI)	P value
TASQ overall summary
Discharge	130	8.2 (5.3 to 11.0)	<0.001	128	−1.8 (−4.5 to 1.0)	0.209
30 days	124	16.9 (13.6 to 2.1)	<0.001	118	9.1 (5.4 to 12.7)	<0.001
3 months	119	19.7 (16.4 to 23.0)	<0.001	121	14.6 (10.8 to 18.3)	<0.001
TASQ physical symptoms
Discharge	130	1.8 (1.3 to 2.2)	<0.001	129	0.3 (−0.1 to 0.7)	0.132
30 days	124	2.4 (1.9 to 2.9)	<0.001	119	1.6 (1.1 to 2.1)	<0.001
3 months	119	2.8 (2.3 to 3.2)	<0.001	122	2.1 (1.6 to 2.7)	<0.001
TASQ physical limitations
Discharge	128	3.2 (2.9 to 4.2)	<0.001	127	0.1 (−1.0 to 1.1)	0.917
30 days	124	7.1 (6.1 to 8.2)	<0.001	119	3.9 (2.8 to 5.1)	<0.001
3 months	119	8.1 (7.1 to 9.1)	<0.001	121	6.1 (4.9 to 7.3)	<0.001
TASQ emotional impact
Discharge	130	2.8 (1.3 to 4.2)	<0.001	127	−0.1 (−1.5 to 1.4)	0.920
30 days	122	5.9 (4.2 to 7.5)	<0.001	119	3.8 (1.8 to 5.7)	<0.001
3 months	119	7.2 (5.4 to 9.0)	<0.001	121	6.4 (4.5 to 8.3)	<0.001
TASQ social limitations
Discharge	127	0.6 (−0.02 to 1.2)	0.058	125	−1.9 (−2.7 to −1.2)	<0.001
30 days	122	2.0 (1.4 to 2.7)	<0.001	119	−0.2 (−1.0 to 0.5)	0.516
3 months	118	2.8 (2.1 to 3.4)	<0.001	122	0.9 (0.2 to 1.5)	0.013
TASQ health expectations
Discharge	127	−0.2 (−0.5 to 0.1)	0.242	128	−0.2 (−0.5 to 0.05)	0.100
30 days	123	−0.8 (−1.1 to −0.4)	<0.001	118	−0.3 (−0.6 to 0.1)	0.120
3 months	119	−1.1 (−1.4 to −0.7)	<0.001	120	−1.0 (−1.4 to −0.5)	<0.001

All questions were used for the total score. Missing values were replaced by the mean score at that follow-up time point, provided that the patient had responded to at least 50% of the questions for that subscale; otherwise, patient questionnaires were excluded.
SAVR, surgical aortic valve replacement; TASQ, Toronto Aortic Stenosis Quality of Life Questionnaire; TAVR, transcatheter aortic valve replacement.